Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis

J Am Acad Dermatol. 2021 Feb;84(2):513-517. doi: 10.1016/j.jaad.2020.10.046. Epub 2020 Oct 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • COVID-19 / complications
  • COVID-19 / epidemiology*
  • Cohort Studies
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Psoriasis / complications
  • Psoriasis / drug therapy*
  • Registries
  • Severity of Illness Index
  • Spain